How were CSL's earnings last quarter?

CSL Limited (ASX:CSL) issued its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, topping the consensus estimate of $4.22 by $0.01. CSL had a trailing twelve-month return on equity of 13.85% and a net margin of 16.48%.

How often does CSL pay dividends? What is the dividend yield for CSL?

CSL declared a Final dividend on Thursday, September 7th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 1.992 per share on Tuesday, October 3rd. This represents a dividend yield of 0.74%. The ex-dividend date is Sunday, September 10th. This is a positive change from the stock's previous Final dividend of A$1.61. Read our dividend analysis for CSL .

Is CSL a good dividend stock?

CSL (ASX:CSL) pays an annual dividend of A$3.63 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 53.70%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CSL .

What other stocks do shareholders of CSL own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP) , Commonwealth Bank of Australia (CBA) , Cochlear (COH) , ResMed (RMD) , Telstra Group (TLS) , Woodside Petroleum (WPL) , Altium (ALU) , Afterpay (APT) , Appen (APX) and Berkshire Hathaway (BRK.B) .

CSL Stock Price, News & Analysis (ASX:CSL)

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 869,289 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 1.37%
Price Target: N/A

About CSL Stock (ASX:CSL)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

December 5, 2023 | bizjournals.com

CSL Plasma awarded $5M judgment against Boca Raton advertising agency

December 5, 2023 | finance.yahoo.com

ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

December 5, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

December 5, 2023 | finance.yahoo.com

ComEd, CSL Highlight Completion of New Electrical Substation to Serve Kankakee Plant, Support Continued Regional Economic Growth

December 5, 2023 | fool.com.au

CSL shares up 15% in 5 weeks amid two hedge funds placing opposing bets

December 3, 2023 | msn.com

‘The sky’s the limit’: can Saudi Arabian football pull off what China failed to do?

December 1, 2023 | msn.com

BMW M2 CS Coming In 2025 With No Manual Transmission

November 29, 2023 | fool.com.au

Could CSL stock be a millionaire-maker at $261

December 5, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

November 28, 2023 | businesswire.com

Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults

November 27, 2023 | msn.com

From bidding for Bale to selling the team bus - the fall of the CSL

November 26, 2023 | msn.com

1-of-50 2023 BMW 3.0 CSL Made Someone Splurge at RM Sotheby’s Munich Auction

November 25, 2023 | msn.com

The Fanatec sim racing power upgrade I've been ever-so-tempted to buy for over a year has $150 off for Black Friday

November 23, 2023 | finance.yahoo.com

Is Carlisle Companies Incorporated's (NYSE:CSL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

November 21, 2023 | msn.com

Are haemophilia gene therapies truly “one and done”?

November 21, 2023 | afr.com

Melbourne earns top marks for research

November 21, 2023 | fool.com.au

What's the outlook for CSL shares in 2024?

November 17, 2023 | seekingalpha.com

CSL Limited: Positive Capital Return And Earnings Growth Expectations

November 17, 2023 | msn.com

M Performance Adds 3.0 CSL Flair To BMW M2 And M3

November 14, 2023 | fool.com.au

Why has Goldman Sachs just upgraded CSL shares?

November 14, 2023 | msn.com

What to Know About Donating Plasma for Money

November 14, 2023 | finance.yahoo.com

Carlisle Companies Commits to Largest Purse in Epson Tour History, with a Three-Year Extension

November 13, 2023 | msn.com

Three unloved sectors (and 5 stocks) that could become tomorrow’s winners

November 13, 2023 | fool.com.au

CSL share price correction! Timely chance to buy the dip?

November 13, 2023 | msn.com

1 Of 50 BMW 3.0 CSLs Is Already Looking For A New Home

November 10, 2023 | msn.com

Aussies unprepared for nastier summer bites and stings

November 10, 2023 | msn.com

Motorious Readers Get Double Entries To Win This BMW M4 CSL and BMW Motorcycle

See More Headlines

Receive CSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/14/2019
Ex-Dividend for 10/3 Dividend: 9/10/2023
Dividend Payable: 10/03/2023
Today: 12/05/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:CSL
CUSIP: N/A
CIK: N/A
Web: www.csl.com.au
Phone: +61-3-93891911
Fax: N/A
Employees: 32,065
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A$6.76
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 1.29
Net Income: $2.19 billion
Net Margins: 16.48%
Pretax Margin: N/A
Return on Equity: 13.85%
Return on Assets: 6.30%

Debt

Debt-to-Equity Ratio: 68.59
Current Ratio: 2.01
Quick Ratio: 1.68

Sales & Book Value

Annual Sales: $13.31 billion
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 207.70
Book Value: A$32.73 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 483,060,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.27

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Dr. Paul F. McKenzie Ph.D. (Age 57)
MD, CEO & Executive Director
Comp: $4.19M
Ms. Joy Carolyn Linton B.Com. (Age 58)
BComm, GAICD, Grad Dip AFI, Chief Financial Officer
Comp: $3.12M
Mr. Mark Dehring
Head of Investor Relations
Mr. Gregory Boss B.S. (Age 62)
BS(Hons), J.D., Executive VP of Legal & General Counsel
Comp: $1.67M
Christina Hickie
Senior Manager of Communications
Dr. Karen Etchberger (Age 65)
Executive Vice President of Quality & Business Services
Comp: $1.57M
Ms. Jemimah Brennan
Head of Communications - Asia Pacific
Mr. William Campbell B.S. (Age 63)
Executive VP & Chief Commercial Officer
Comp: $1.85M
Dr. Andrew D. Nash (Age 61)
Senior Vice President of Research
Dr. William Mezzanotte M.D. (Age 64)
M.P.H., Executive VP & Head of Research and Development
Comp: $2.22M

Key Competitors

View All Competitors

Insiders

CSL Stock Analysis - Frequently Asked Questions

How were CSL's earnings last quarter?: CSL Limited (ASX:CSL) issued its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, topping the consensus estimate of $4.22 by $0.01. CSL had a trailing twelve-month return on equity of 13.85% and a net margin of 16.48%.
How often does CSL pay dividends? What is the dividend yield for CSL?: CSL declared a Final dividend on Thursday, September 7th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 1.992 per share on Tuesday, October 3rd. This represents a dividend yield of 0.74%. The ex-dividend date is Sunday, September 10th. This is a positive change from the stock's previous Final dividend of A$1.61.
Read our dividend analysis for CSL.
Is CSL a good dividend stock?: CSL (ASX:CSL) pays an annual dividend of A$3.63 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 53.70%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CSL.
What other stocks do shareholders of CSL own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), ResMed (RMD), Telstra Group (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay (APT), Appen (APX) and Berkshire Hathaway (BRK.B).

This page (ASX:CSL) was last updated on 12/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial